Matthew I. Milowsky
Papers
3
Total Citations
621
H-Index
2
About
Matthew I. Milowsky is a leading authority in urologic oncology, with a primary focus on muscle-invasive and metastatic bladder cancer. His major contributions center on advancing treatment paradigms through the development and refinement of clinical guidelines and surgical approaches. As a key contributor to the European Association of Urology (EAU) Guidelines on Muscle-invasive and Metastatic Bladder Cancer, his work—most notably the 2023 summary, which has garnered over 611 citations—provides a critical, evidence-based framework for clinicians worldwide, shaping standard-of-care decision-making. Milowsky has also explored the oncologic outcomes of robot-assisted versus open radical cystectomy in patients receiving perioperative chemotherapy, offering valuable insights into surgical efficacy and patient outcomes. His research has had a profound impact on the field, influencing both clinical practice and future investigative directions. Through his leadership in guideline development and his commitment to improving treatment strategies, Milowsky has established himself as a pivotal figure in the fight against bladder cancer, guiding the next generation of researchers and clinicians.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3